NEUROENDOCRINE TUMOR OF PANCREAS
Clinical trials for NEUROENDOCRINE TUMOR OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR OF PANCREAS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare pancreatic cancer: experimental drug enters trial
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called lurbinectedin in people with high-grade pancreatic neuroendocrine tumors (a rare, fast-growing cancer) who have already tried standard treatments. The goal is to see if the drug can shrink or control the tumor. About 46 adults will take part in this…
Matched conditions: NEUROENDOCRINE TUMOR OF PANCREAS
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New radioactive drug tested for Hard-to-Treat tumors
Disease control OngoingThis early-stage study tests a new radioactive drug called [212Pb] VMT-alpha-NET in 24 adults with advanced neuroendocrine tumors that have stopped responding to other treatments. The main goal is to find a safe dose for future studies, not to provide direct benefit. Participants…
Matched conditions: NEUROENDOCRINE TUMOR OF PANCREAS
Phase: EARLY_PHASE1 • Sponsor: David Bushnell • Aim: Disease control
Last updated May 11, 2026 20:38 UTC